Li, W., Dong, X., He, C., Tan, G., Li, Z., Zhai, B., . . . Sun, X. (2019). LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells. J Exp Clin Cancer Res.
Chicago Style aipamenaLi, Weidong, et al. "LncRNA SNHG1 Contributes to Sorafenib Resistance By Activating the Akt Pathway and Is Positively Regulated By MiR-21 in Hepatocellular Carcinoma Cells." J Exp Clin Cancer Res 2019.
MLA aipamenaLi, Weidong, et al. "LncRNA SNHG1 Contributes to Sorafenib Resistance By Activating the Akt Pathway and Is Positively Regulated By MiR-21 in Hepatocellular Carcinoma Cells." J Exp Clin Cancer Res 2019.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.